Spark recruits gene therapy expert Mingozzi as new CSO; Fusion brings venture round to $46M; China OKs Gilead’s Sovaldi for hep C
⇨ Spark Therapeutics $ONCE has recruited Federico Mingozzi, a noted gene therapy expert at INSERM and Genethon in France, as chief scientific officer. Mingozzi picked up his PhD at the University of Ferrara, Italy and an MBA from Drexel University in Philadelphia.
⇨ The former SVP for diabetes marketing at Novo Nordisk has been poached by Biogen to take the same lead on their Alzheimer’s franchise. Camille Lee will be in charge of marketing strategy on Alzheimer’s, provided Biogen gets any through the regulatory approval process. She reports now to Al Sandrock.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
